COURT-RULING ·Filed Jul 23, 2026

CORT

CORCEPT THERAPEUTICS INC
BULLISH
Impact 4/10
Horizonweeks Processed2mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight ▲ Bullish

This is a modest positive for CORT — it removes a discovery distraction and signals the court is not expanding the scope of the case. However, the underlying Teva lawsuit remains active; monitor for summary judgment motions or trial dates. The stock's strong historical momentum (avg +16% T+20 on prior calls) suggests the market is already pricing in favorable outcomes.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
CORT ▲ +25.23% at T+20d
LONG call ✓ call won +25.23% · α vs SPY +21.92% · entry $96.66 → $121.05
Next anchor: T+60d in 13d
Latest observation: T+47 -31.70% FF3 residual α
Entry anchored
Jul 22, 03:59 PM ET
via exchange tick
T+1d
-1.34%
call -1.34% · α -1.45%
$95.36
settled 2mo ago
T+5d
+22.41%
call +22.41% · α +21.93%
$118.32
settled 2mo ago
T+20d
+25.23%
call +25.23% · α +21.92%
$121.05
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

The court denied Teva's motion to compel Corcept to produce text messages from DOJ materials in this patent/antitrust litigation. The ruling is a procedural discovery win for Corcept — the court found no prior agreement to produce texts and deemed the request untimely and disproportionate. This removes a near-term discovery burden and marginally reduces litigation risk, but the underlying case continues.

Court Ruling Details

Ruling Date
Jul 23, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
Virginia K. DeMarchi
Case Type
patent
Ruling Type
discovery
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • Court denied Teva's request to compel production of text messages from DOJ materials
  • Ruling based on lack of prior agreement and proportionality concerns
  • Underlying Teva lawsuit against Corcept continues — this is a procedural discovery win, not a case-ending ruling
  • Corcept had already produced nearly 9,000 documents from DOJ materials

Financial Impact

No damages awarded or financial exposure quantified in this ruling. Procedural win avoids incremental discovery costs and potential adverse evidence.

legal_expenseslitigation_risk

Risk Factors

  • Teva's underlying lawsuit against Corcept continues — this ruling does not resolve the case
  • DOJ qui tam action referenced in the opinion remains a separate overhang
  • Discovery disputes may resurface on other document categories

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-dec579e875-CORT
26 reports for CORT
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+60▲ +63.06%Feb 24, 2026
Filters
Rows
Reports for CORT — sortable, filterable
TypeNow
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $115.63▲ +1.54%▲ +1.28%$116.23 (+2.06%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $116.10▲ +1.95%▲ +1.44%$116.23 (+2.06%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$116.93 $117.00▲ +0.06%▲ +0.16%$116.23 (−0.60%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$121.05 $114.86▼ −5.11%▼ −5.11%$116.23 (−3.98%)
Aug 18, 2026
6w ago
Insider Cluster
BEARISH ★ 4/10
$118.10 $111.85▲ +5.29%▲ +4.30%$116.23 (+1.58%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.23 (+3.61%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.23 (+3.61%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$110.77 $111.62▲ +0.77%▲ +1.16%$116.23 (+4.93%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.95 $112.80▲ +4.49%▲ +3.89%$116.23 (+7.67%)
Jul 23, 2026
10w ago
Court Ruling
BULLISH ★ 4/10
$96.66 $121.05▲ +25.23%▲ +21.92%$116.23 (+20.25%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (65h 24m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access